Kerala’s Senior Citizens Care Bill, 2026, introduces enforceable standards for geriatric care, regulates elderly care facilities, recognizes living wills, and strengthens protection against abuse.
Indian pharma innovation is gaining momentum as companies and policymakers focus on R&D investment, clinical trials, and new drug development.
Johnson & Johnson doubles down on Ortho breakup plans as a 6% share collapse contrasts with strong pharmaceutical earnings and medical device pressures.
Pharma’s Day of Deals spotlights an AI obesity push, a digital pathology buy, and fresh funds for Indian biotech innovation.
HPV-targeted cancer therapy faces a setback as BioNTech's BNT113 misses its first major clinical trial endpoint in head and neck cancer.
Zydus' Keytruda biosimilar FYB206 enters FDA review without a comparative Phase III efficacy trial, highlighting a shift in biosimilar development.
ALK7 RNAi therapy is emerging as a potential alternative approach to obesity treatment as Roche expands its experimental drug pipeline.
Karnataka introduces transparent medicine pricing details on hospital bills from November 1, helping patients compare procurement costs, MRP and final charges.
ReadyFlow works equally well in the arm or thigh, with new data supporting consistent drug exposure and diuretic effects.
Lung health research advances on two fronts as scientists link microbiome changes to lingering Covid symptoms, while IPF drug trials deliver contrasting results.
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")
